News

Pharmabiz7m
Autonomix Medical receives approval from Republic of Uzbekistan to expand proof-of-concept human clinical study
Autonomix Medical receives approval from Republic of Uzbekistan to expand proof-of-concept human clinical study: The Woodlands, Texas Saturday, June 7, 2025, 18:00 Hrs [IST] Auton ...
Pharmabiz2h
Ocugen signs binding term sheet for license of OCU400 modifier gene therapy for retinitis pigmentosa in Korea
Ocugen signs binding term sheet for license of OCU400 modifier gene therapy for retinitis pigmentosa in Korea: Malvern, Pennsylvania Saturday, June 7, 2025, 16:00 Hrs [IST] Ocugen ...
Pharmabiz1h
CancerVax creates a ligand conjugated nanoparticle to target specific biomarkers on surface of cancer cells
CancerVax creates a ligand conjugated nanoparticle to target specific biomarkers on surface of cancer cells: Lehi, Utah Saturday, June 7, 2025, 17:00 Hrs [IST] CancerVax, Inc, the ...
Pharmabiz10h
NABH instructs all HCOs to ensure that their facility names accurately represent the services they provide
NABH instructs all HCOs to ensure that their facility names accurately represent the services they provide: Shardul Nautiyal, ...
Pharmabiz10h
CDSCO adds 7 labs to test Covid-19 IVD medical devices for performance evaluation
CDSCO adds 7 labs to test Covid-19 IVD medical devices for performance evaluation: Gireesh Babu, New Delhi Saturday, June 7, ...
Pharmabiz10h
PCI to conduct orientation programme on ranking and rating for UG institutes
PCI to conduct orientation programme on ranking and rating for UG institutes: Our Bureau, New Delhi Saturday, June 7, 2025, ...
Pharmabiz3h
Oncovita secures US FDA orphan drug designation for its lead oncolytic virus candidate, MVdeltaC to treat pleural mesothelioma
Oncovita secures US FDA orphan drug designation for its lead oncolytic virus candidate, MVdeltaC to treat pleural mesothelioma: Paris Saturday, June 7, 2025, 15:00 Hrs [IST] Oncov ...
Pharmabiz4h
Simultaneous treatment start with finerenone and SGLT-2-inhibitor demonstrated positive data in patients with CKD associated with type 2 diabetes
Simultaneous treatment start with finerenone and SGLT-2-inhibitor demonstrated positive data in patients with CKD associated with type 2 diabetes: Berlin Saturday, June 7, 2025, 1 ...
Pharmabiz5h
Fujirebio collaborates with Stanford Medicine to advance research and innovation in the field of infectious disease testing
Fujirebio collaborates with Stanford Medicine to advance research and innovation in the field of infectious disease testing: Tokyo, Japan Saturday, June 7, 2025, 13:00 Hrs [IST] F ...
Pharmabiz7h
Biocytogen secures Japanese patent for RenMab platform; expands global patent portfolio for RenMice fully human antibody
Biocytogen secures Japanese patent for RenMab platform; expands global patent portfolio for RenMice fully human antibody: Beijing Saturday, June 7, 2025, 11:00 Hrs [IST] Biocytoge ...
Pharmabiz6h
HeartSciences receives US FDA breakthrough device designation for its AI-ECG algorithm for detecting aortic stenosis
HeartSciences receives US FDA breakthrough device designation for its AI-ECG algorithm for detecting aortic stenosis: Southlake, Texas Saturday, June 7, 2025, 12:00 Hrs [IST] Hear ...
Pharmabiz8h
AstriVax begins clinical development of AVX70371, a hepatitis B immunotherapy using Launch-iT technology
AstriVax begins clinical development of AVX70371, a hepatitis B immunotherapy using Launch-iT technology: Leuven, Belgium Saturday, June 7, 2025, 10:00 Hrs [IST] AstriVax Therapeu ...